SERA Stock Analysis: Buy, Sell, or Hold?
SERA - Sera Prognostics, Inc. Class A Common Stock
$2.05
-0.12 (-5.53%)
▼
5d:
+0.0%
30d:
+13.89%
90d:
-3.3%
BUY
HIGH Confidence
Analysis Updated: Jul 24, 2026 12:00 AM ET
Earnings: Aug 05, 2026
9d
Get Alerted When SERA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: SERA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: SERA shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: SERA is currently trading at $2.05, which is considered fair relative to its 30-day fair value range of $1.84 to $2.12.
Technical Outlook: Technically, SERA is showing sideways momentum. Immediate support is located at $1.90, while resistance sits at $2.30. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: SERA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.50 (+168.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, SERA is showing sideways momentum. Immediate support is located at $1.90, while resistance sits at $2.30. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: SERA has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.50 (+168.3%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$1.84 -
$2.12
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
81.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 168.3% below Wall St target ($5.50)
Trading Range Analysis
30-Day Trading Range
$1.84 -
$2.12
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$1.90
Resistance Level
$2.30
Current Trend
Sideways
Technical data as of
Jul 24, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-3.55
Wall Street Target
$5.50
(+168.3%)
Revenue Growth (YoY)
-63.2%
Share & Embed Analysis
Last updated: July 26, 2026 2:51 PM ET
Data refreshes hourly during market hours. Next update: 3:51 PM
Data refreshes hourly during market hours. Next update: 3:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is SERA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
15
Sells
Net
INSIDERS SELLING
Recent Transactions
Austin Aerts
SELL
1019 shares
2026-03-11
Zhenya Lindgardt
SELL
2973 shares
2026-03-11
Robert Gardner Harrison
SELL
716 shares
2026-03-11
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$72 | 54 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$387 | 47 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$119 | 52 HOLD |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$98 | 56 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$238 | 50 HOLD |
